[1] Cong Q, Li G, Wang Y, et al.DW-MRI for esophageal squamous cell carcinoma, correlations between ADC values with histologic differentiation and VEGF expression: a retrospective study[J].Oncol Lett,201,34(9):103-105. [2] Huang R, Wang F, Yang Y, et al.Recurrent activations of transient receptor potential vanilloid-1 and -4 promote cellular proliferation and migration in esophageal squamous cell carcinoma cells[J].FEBS Open Bio,2018,28(6):45-47. [3] 王栋,刘清,郑树涛,等.TGF-β1促进食管癌上皮间质转化的发生发展[J].新疆医科大学学报,2015,38(12):1471-1475. [4] 吴广银,杨红杰,韩倩,等.胰岛素样生长因子-1受体抑制剂对食管癌放疗增敏的研究[J].中华实验外科杂志,2015,32(3):550-552. [5] Kuwabara H, Abe S, Nonaka S, et al.Clinical feasibility of endoscopic submucosal dissection with minimum lateral margin of superficial esophageal squamous cell carcinoma[J].Endosc Int Open,2019,7(4):396-402. [6] Li Q, Zhu S, Li S, et al.Elective nodal irradiation provides a superior therapeutic modality for lymph node positivity esophageal squamous cell carcinoma patients receiving definitive radiotherapy versus involved-field irradiation[J].Medicine,2019,98(3):4080-4083. [7] Lindner K, Eichelmann A, Matuszcak C, et al.Correction: complex epigenetic regulation of chemotherapy resistance and biology in esophageal squamous cell carcinoma via microRNAs[J].Int J Mol Sci,2019,20(4):921-924. [8] 唐玲荣,李光,党军,等.hMOF蛋白在食管癌中的表达及其与放射治疗预后的关系[J].中国医科大学学报,2017,46(10):903-908. [9] 徐越,吴宛君,白美玲,等.TGFBI和TCTP在食管癌组织中的表达及肿瘤耐药相关性[J].河北北方学院学报(自然科学版),2017,33(4):1-3. [10] 徐志彬,冯军波,郑秀丽,等.不同食管病变组织中TGFβ1、α-SMA、smad4、VEGF蛋白表达及MVD比较[J].山东医药,2016,56(6):10-12. [11] 张娟,曹婷婷.食管癌患者血清血管内皮生长因子、胰岛素样生长因子-1表达及其与临床病理特征的关系[J].中国实验诊断学,2018,22(7):1152-1155. [12] 周敏杰,李少民,夏焘,等.食管癌患者术前术后血清Hcy、TSGF、IGF-Ⅱ的改变及临床意义[J].海南医学,2017,28(8):1278-1280. [13] 贾征,张立国,李军,等.贲门癌及食管癌外周血免疫调节因子TGF-β1和IL-10及相关抗原自身抗体的变化及临床意义[J].中国微生态学杂志,2017,29(9):1073-1075. [14] 林瑶,陈克能.预测食管癌术前放化疗敏感性分子的研究进展[J].中华胃肠外科杂志,2015,18(9):953-957. [15] 刘连科,邵明雯,马兰,等.食管癌伴神经内分泌分化的临床病理特点及诊断标志物[J].山东大学学报(医学版),2015,53(7):87-91. [16]刘本刚,张帆,王建军,等.消化系统恶性肿瘤患者的生存时间以及相关因素的研究[J].实用预防医学,2016,23(9):1107-1109.